News & Updates

Show Multimedia Only

Sorafenib plus hepatic arterial infusion chemo safe, effective in advanced HCC

03 Sep 2020

Treatment with sorafenib plus hepatic arterial infusion chemotherapy (SoraHAIC) for advanced hepatocellular carcinoma (HCC) has been shown to be safe and effective in a recent study.

Sorafenib plus hepatic arterial infusion chemo safe, effective in advanced HCC

03 Sep 2020

Nintedanib continues to show promise for progressive fibrosing ILDs

03 Sep 2020 by

Interim analyses of the INBUILD trial presented at ATS 2020 continue to reflect the benefit of the tyrosine kinase inhibitor nintedanib for individuals with progressive fibrosing interstitial lung diseases (ILDs).

Nintedanib continues to show promise for progressive fibrosing ILDs

03 Sep 2020

Systemic JIA: Tapering canakinumab feasible in children in complete remission

03 Sep 2020

For paediatric patients who achieved complete remission (CR) on canakinumab, it is possible to maintain this response while reducing exposure to the drug, as shown in a study.

Systemic JIA: Tapering canakinumab feasible in children in complete remission

03 Sep 2020

News & Updates

Filter by Specialty:

Specialty:

Sorafenib plus hepatic arterial infusion chemo safe, effective in advanced HCC

Sorafenib plus hepatic arterial infusion chemo safe, effective in advanced HCC

Nintedanib continues to show promise for progressive fibrosing ILDs

Nintedanib continues to show promise for progressive fibrosing ILDs

Systemic JIA: Tapering canakinumab feasible in children in complete remission

Systemic JIA: Tapering canakinumab feasible in children in complete remission